SQSTM1 and central nervous system cancer: In the central nervous system (CNS), p62 has been formerly studied in neurodegenerative disorders, such as Parkinson's and Alzheimer's diseases [21, 22, 23], while the role of p62 in gliomas is still debated [24, 25].